Clinical Studies and Case Reports

On this site you will find clinical studies with cannabis or single cannabinoids in different diseases and case reports on the use of cannabis by patients.
You may search for diseases (indications), authors, medication, study design (controlled study, open trial, case report etc.) and other criteria.

[Back to Overview]  [IACM Homepage]

TitleExperiences with THC-treatment in children and adolescents
Author(s)Lorenz R
Journal, Volume, IssueAbstract, IACM 2nd Conference on Cannabinoids in Medicine, September 12-13, 2003, Cologne
Major outcome(s)Positive effects of THC in children with severe neurological disorders

8 patients children or adolescents aged 3 to 14 years have been treated with Ä9-THC, dosages ranged from 0.04 mg/kg body weight to 0.14 mg/kg body weight.
In an 8 year-old-boy with NCL Jansky-Bielschowsky spasticity was diminished, he became more alert and his mood improved.
In a 12 year-old-girl, who had suffered from severe hypoxia during birth, mood improved, awareness was increased and focal seizures (presenting as nystagmus and versive movement) but not tonic-clonic seizures were reduced.
A 12 year-old-girl with PDHC-deficiency became more interested in her surroundings and society. Nodding spasms and tonic seizures decreased.
In a 14 year-old-girl with marked dystonia due to NCL Spielmeyer-Vogt a reduction of abnormal movement patterns was observed. In addition the girl had more initiative.
In a 13 year-old-boy presenting with spasticity, athetosis, myoclonic movements and epileptic seizures of unknown cause interest in his surroundings was improved, myoclonic movements were less intense but of similar frequency. Frequency and duration of his focal and generalized seizures were not influenced.
In an 11 year-old-girl with a traumatic paraplegia a significant improvement of symptoms of a posttraumatic reaction presenting as an eating disorder and negative behaviour was observed. Taking higher doses the girl started to develop side effects including inappropriate language (concerning sexual content) and very associative thinking. Therapy was discontinued without signs of withdrawal.
In a 3 10/12 year-old-boy with a traumatic paraplegia a significant improvement in his behaviour and eating disorder was observed.
In a 14 year-old-boy suffering from intractable epilepsy and severe mental retardation appetite and mood improved. Frequency of seizures seemed not to be influenced, but clear assessment was not possible because antiepileptic drugs were changed.
Conclusion: In severly disabled children and adolescents Ä9-THC-medication can have positive psychotropic effects, influences the degree of spasticity and dystonia and-occasionally-seems to have an anticonvulsant action.

Dose(s)0.04 - 0.14 mg/kg body weight
Duration (days)
Participants8 children with different neurological disorders
DesignUncontrolled case report
Type of publicationMeeting abstract
Address of author(s)Paediatrician, Brunnenstrasse 54, 34537 Bad Wildungen, Germany
Full text

[Back to Overview]  [IACM Homepage]